Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Iroko Pharmaceuticals Enters into Strategic Agreements to Expand Commercialization of ZORVOLEXTM (diclofenac) Outside the U.S

VIEWS: 0 PAGES: 3

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., has signed licensing agreements with Algorithm SAL and PT Pratapa Nirmala (Fahrenheit), under which the two companies will obtain the exclusive rights to market and sell ZORVOLEX™ (diclofenac) capsules to countries in the Middle East, North Africa (MENA) and Indonesia, respectively. U

More Info
To top